WHO ICTRP trial
A study to test the effect of Pepzyme Pro on the digestion and absorption of Pea…
CTRI/2021/10/037072 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/10/037072 |
|---|---|
| Public title | A study to test the effect of Pepzyme Pro on the digestion and absorption of Pea protein |
| Scientific title | A prospective, randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of dietary supplement Pepzyme Pro on the digestion and absorption of Pea protein. |
| Primary sponsor | Advanced Enzymes Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Interventions | Intervention1: Pepzyme Pro: Pea protein (30g) + Pepzyme Pro (1% of the protein) for 15 days. Control Intervention1: Identical Placebo: Pea protein (30g) + Placebo supplement (1% of the protein) for 15 days. |
| Registration date | Apr 10, 2021 |
| Target size | 15 |
| Secondary IDs | AETL/CT/Pepzyme Pro/02/2021 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: